How does hepatitis B "big three positive" turn into "small three positive"?

In general, hepatitis B "large three positive" (HBeAg-positive) cannot be completely converted to "small three positive" (HBeAg-negative), but antiviral therapy can reduce viral load and slow disease progression. Detailed analysis is as follows:

Hepatitis B vaccination can prevent infection with the hepatitis B virus. For those already infected, it may also help reduce viral replication and lower the risk of liver cancer and cirrhosis. It is important to maintain a healthy lifestyle—quit smoking, limit alcohol consumption, avoid overeating and excessive fatigue, ensure adequate sleep, eat more fruits, vegetables, and whole grains, and avoid exposure to infectious sources. Patients with hepatitis B should undergo regular monitoring of liver function, viral load, and screening for liver cancer to track disease progression and adjust treatment plans promptly, while closely watching for adverse reactions such as liver damage. Additionally, patients may take antiviral medications as prescribed by a physician, such as entecavir tablets or tenofovir tablets, which can reduce hepatitis B viral load and suppress viral replication, thereby slowing disease progression.

It should be noted that patients with hepatitis B "large three positive" must have alanine aminotransferase (ALT) levels more than twice the upper limit of normal before initiating antiviral therapy.